A recent study indicates that the effectiveness of GLP-1 receptor agonists, including Ozempic and Wegovy, may be significantly diminished for individuals who overeat due to emotional...
Health insurance premiums in the United States are projected to experience their largest increase in five years, primarily driven by the growing utilization of weight loss...
The World Health Organization (WHO) has officially added GLP-1 weight loss medications to its Essential Medicines List for the first time. This significant development, announced in...
As the popularity of GLP-1 medications like Ozempic continues to rise, health authorities are warning users of potential new side effects related to dental health. Reports...
Serena Williams has publicly discussed her decision to use GLP-1 medications for weight loss, revealing that she lost 31 pounds over eight months following the births...
Renowned health economist John Cawley has been appointed as the Daniel Patrick Moynihan Chair in Public Policy at the Maxwell School of Citizenship and Public Affairs,...
Eli Lilly’s recent data indicates that its GLP-1 obesity medication is less effective than a similar product from Novo Nordisk. The company reported that patients lost...
